Immunohistochemical analysis of the oxidative phosphorylation complexes in skeletal muscle from patients with mitochondrial DNA encoded tRNA gene defects

Journal of Clinical Pathology

Volumn 62, Issue 2, 2009, Pages 172-176

  De Paepe, B ^a,e   Smet, J ^a   Lammens, M ^b   Seneca, S ^c   Martin, J J ^d   De Bleecker, J ^a   De Meirleir, L ^a   Lissens, W ^c   Van Coster, R ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c University Hospital for Children   (Belgium)

^d ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^e NONE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C OXIDASE; MITOCHONDRIAL DNA; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); TRANSFER RNA; UBIQUINOL CYTOCHROME C REDUCTASE;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNODETECTION; IMMUNOHISTOCHEMISTRY; MALE; MELAS SYNDROME; MERRF SYNDROME; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; SKELETAL MUSCLE;

ADULT; BIOLOGICAL MARKERS; DNA, MITOCHONDRIAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; MALE; MIDDLE AGED; MITOCHONDRIAL MYOPATHIES; MULTIENZYME COMPLEXES; MUSCLE, SKELETAL; MUTATION; OXIDATIVE PHOSPHORYLATION; RNA, TRANSFER;

EID: 61449091466     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2008.061267     Document Type: Article

References (22)

1. Smeitinck J, van den Heuvel L, DiMauro S. The genetics and pathology of oxidative phosphorylation. Nat Rev Genet 2001;2:342-52.
2. Anderson S, Bankier AT, Barrell BG, et al. Sequence and organization of the human mitochondrial genome. Nature 1981;290:457-65.
3. DiMauro S, Shon EA. Mitochondrial respiratory-chain diseases. N Engl J Med 2003;348:2656-68.
4. Rahman S, Lake BD, Taanman JW, et al. Cytochrome oxidase immunohistochemistry: clues for genetic mechanisms. Brain 2000;123:591-600.
5. Scalais E, Nuttin C, Seneca S, et al. Infantile presentation of the mitochondrial A8344G mutation. Eur J Neurol 2007;14:e3-5.
6. Meulemans A, De Paepe B, De Bleecker J, et al. Two novel mitochondrial DNA mutations in muscle tissue of a patient with limb-girdle myopathy. Arch Neurol 2007;64:1339-43.
7. Fisher JC, Ruitenbeek W, Gabreëls FJM, et al. A mitochondrial encephalomyopathy: the first case with an established defect at the level of coenzyme Q. Eur J Pediatr 1986;144:441-4.
8. Rustin P, Chretien D, Bourgeron T, et al. Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 1994;228:35-51.
9. Birch-Machin MA, Shepherd IM, Watmough NJ, et al. Fet al lactic acidosis in infancy with a defect of complex III of the respiratory chain. Pediatr Res 1989;25:553-9.
10. DiMauro S, Servidei S, Zeviani M, et al. Cytochrome c oxidase deficiency in Leigh syndrome. Ann Neurol 1987;22:498-506.
11. Srere PA. Citrate synthase. Methods Enzymol 1969;13:3-11.
12. Van Coster R, Smet J, George E, et al. Blue native polyacrylamide gel electrophoresis: a powerful tool in diagnosis of oxidative phosphorylation defects. Pediatr Res 2001;50:1-8.
13. Seneca S, Lissens W, Liebaers I, et al. Pitfalls in the diagnosis of mtDNA mutations. J Med Genet 1998;35:963-4.
14. Naviaux RK. Developing a systemic approach to the diagnosis and classification of mitochondrial disease. Mitochondrion 2004;4:351-61.
15. Carrozzo R, Wittig I, Santorelli FM, et al. Subcomplexes of human ATP synthase mark mitochondrial biosynthesis disorders. Ann Neurol 2006;59:265-75.
16. Smet J, Seneca S, De Paepe B, et al. Subcomplexes of mitochondrial complex V reveal mutations in mtDNA (submitted).
17. Hanson BJ, Capaldi RA, Marusich MF, et al. An immunocytochemical approach to detection of mitochondrial disorders. J Histochem Cytochem 2002;50:1281-8.
18. De Paepe B, Smet J, Leroy JG, et al. Diagnostic value of immunostaining in cultured skin fibroblasts from patients with oxidative phosphorylation defects. Pediatr Res 2006;59:1-5.
19. Bourgeois JM, Tarnopolsky MA. Pathology of skeletal muscle in mitochondrial disorders. Mitochondrion 2004;4:441-52.
20. Petruzzella V, Moraes CT, Sano MC, et al. Extremely high levels of mutant mtDNAs co-localize with cytochrome c oxidase-negative ragged-red fibers in patients harboring a point mutation at nt3243. Hum Mol Genet 1994;3:449-54.
21. Silvestri G, Rana M, Odoardi F, et al. Single-fiber PCR in MELAS(3243) patients: correlations between intratissue distribution and phenotypic expression of the mtDNA A3243G genotype. Am J Med Genet 2000;94:201-6.
22. James AM, Wei YH, Pang CY, et al. Altered mitochondrial function in fibroblasts containing MELAS and MERRF mitochondrial DNA mutations. Biochem J 1996;318:401-7.